Catalog No.
YVV04601
Expression system
E. coli
Species
Human herpesvirus 1 (HSV-1/HHV-1)
Protein length
Gly24-Asp189
Predicted molecular weight
43.82 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P06484
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Envelope glycoprotein G, gG, gG-1, gG, US4
CTLA4 Single-Nucleotide Polymorphisms Influence the Risk of HSV and VZV Infection in Kidney Transplant Recipients: A Prospective Cohort Study., PMID:40469083
Herpes simplex virus type 1 modifies the protein composition of extracellular vesicles to promote neurite outgrowth and neuroinfection., PMID:38275838
Phylogenetic and Genomic Characterization of Whole Genome Sequences of Ocular Herpes Simplex Virus Type 1 Isolates Identifies Possible Virulence Determinants in Humans., PMID:37450309
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G., PMID:36114130
Herpes Simplex Virus 1 Glycoproteins Differentially Regulate the Activity of Costimulatory Molecules and T Cells., PMID:36094100
A Baseline Cellular Antiviral State Is Maintained by cGAS and Its Most Frequent Naturally Occurring Variant rs610913., PMID:35851540
Identification of the Cleavage Domain within Glycoprotein G of Herpes Simplex Virus Type 2., PMID:33322659
Complement and CD4+ T cells drive context-specific corneal sensory neuropathy., PMID:31414985
The PILRA G78R Variant Correlates with Higher HSV-1-Specific IgG Titers in Alzheimer's Disease., PMID:31297637
Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population., PMID:30814317
Expression and characterization of the soluble form of recombinant mature HSV-2 glycoprotein G for use in anti-HSV-2 IgG serodiagnostic immunoassay., PMID:29104048
Comparison of commercial methods of immunoblot, ELISA, and chemiluminescent immunoassay for detecting type-specific herpes simplex viruses-1 and -2 IgG., PMID:28332725
Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections., PMID:28238255
Herpes simplex virus particles interact with chemokines and enhance cell migration., PMID:27692045
False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands., PMID:26755775
Binding of the pathogen receptor HSP90AA1 to avibirnavirus VP2 induces autophagy by inactivating the AKT-MTOR pathway., PMID:25714412
Herpes simplex virus enhances chemokine function through modulation of receptor trafficking and oligomerization., PMID:25625471
Secreted herpes simplex virus-2 glycoprotein G modifies NGF-TrkA signaling to attract free nerve endings to the site of infection., PMID:25611061
Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential., PMID:25532518
Development of a time-resolved fluorescence immunoassay for herpes simplex virus type 1 and type 2 IgG antibodies., PMID:25377426
Identification of an immunodominant epitope in glycoproteins B and G of herpes simplex viruses (HSVs) using synthetic peptides as antigens in assay of antibodies to HSV in herpes simplex encephalitis patients., PMID:25283862
IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections., PMID:24496316
Contributions of herpes simplex virus 1 envelope proteins to entry by endocytosis., PMID:24109213
Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology., PMID:23514126
Molecular characterization of clinical isolates of herpes simplex virus type 1 collected in a tertiary-care hospital in Dublin, Ireland., PMID:23508909
A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo., PMID:23341013
Evaluation of antibodies against glycoprotein D (gD) and glycoprotein G (gG) in HSV-1 infected individuals' serum samples., PMID:22696877
Characterization of the viral O-glycopeptidome: a novel tool of relevance for vaccine design and serodiagnosis., PMID:22491453
Phylogenetic comparison of exonic US4, US7 and UL44 regions of clinical herpes simplex virus type 1 isolates showed lack of association between their anatomic sites of infection and genotypic/sub genotypic classification., PMID:22416856
Prevalence of herpes simplex virus type 1 glycoprotein G (gG) and gI genotypes in patients with different herpetic diseases during the last four decades., PMID:22337305
Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses., PMID:22319442
Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling., PMID:22318154
Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006., PMID:22085620
Characterization of herpes simplex virus clinical isolate Y3369 as a glycoprotein G variant and its bearing on virus typing., PMID:21658271
Prevalence and risk factors for herpes simplex infection among patients at high risk for HIV infection in Brazil., PMID:21595666
Application and expression of HSV gG1 protein from a recombinant strain., PMID:20705103
The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies., PMID:20171247
Natural zoonotic infections of two marmosets and one domestic rabbit with herpes simplex virus type 1 did not reveal a correlation with a certain gG-, gI- or gE genotype., PMID:20121821
Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2., PMID:20007366
A 10-year molecular survey of herpes simplex virus type 1 in Germany demonstrates a stable and high prevalence of genotypes A and B., PMID:19186100
Prevalence of herpes simplex virus type 1 glycoprotein G (gG) and gI genotypes in patients with herpetic keratitis., PMID:18617539
Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera., PMID:17989200
Production of recombinant gG-1 protein of herpes simplex virus type 1 in a prokaryotic system in order to develop a type-specific enzyme-linked immunosorbent assay kit., PMID:17521395
Genotyping of clinical herpes simplex virus type 1 isolates by use of restriction enzymes., PMID:17035491
[Expression of multi-copy and immuno-reactivity of recombinant type-specific epitope of herpes simplex virus type 1]., PMID:16894929
Comparison of immunoassays for differentiation of herpes simplex virus type 1 and 2 antibodies., PMID:16758036
Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study., PMID:16709538
Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axons., PMID:16537627
Role of T-lymphocyte subsets in facial nerve paralysis owing to the reactivation of herpes simplex virus type 1., PMID:15966705
Production of herpes B virus recombinant glycoproteins and evaluation of their diagnostic potential., PMID:15695655
For research use only. Not for human or drug use.
